Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medizinska AkadfiledCriticalMedizinska Akad
Priority to BG9437291ApriorityCriticalpatent/BG51278A1/en
Publication of BG51278A1publicationCriticalpatent/BG51278A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The method is applied for treatment of anaemia, in particular symptomatic anaemia upon chronical kidney insufficiency. It attains faster therapeutic effect with lower starting and sustained doses and improves the rehabilitation of the patients. Before the start and during the treatment the serum calcium levels are maintained at 2.40 to 2.60 mmol/l.
BG9437291A1991-05-081991-05-08Method for potentiation of the therapeutical effect of human recombination erythropoietin
BG51278A1
(en)